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Abstract
Purpose: The middle cerebral artery (MCA) is the second most common location of intracerebral aneurysms. Tradi-
tionally, they are treated by microsurgical clipping, but with the development of new techniques and devices endo-
vascular embolisation is gaining more importance. The aim of this study was to summarise six years of experience 
of our department in endovascular treatment of MCA aneurysms.
Material and methods: Forty patients with 41 MCA aneurysms treated in a single centre were included in this study. 
Data on patients’ comorbidities, aneurysm morphology, and treatment course were collected, with special emphasis 
on complications.
Results: There were no statistically significant differences in terms of aneurysm morphology between males and 
females and between ruptured and unruptured aneurysms. None of the diseases analysed in the current study were 
linked with significantly increased risk of SAH. Unruptured aneurysms were significantly more frequently treated 
by stent-assisted coiling (30.4% vs. 5.6%, p = 0.0388) than were ruptured aneurysms, while ruptured aneurysms were 
treated more frequently by coiling alone (77.8% vs. 34.8%, p = 0.0062). After an initial course of treatment 63.4%  
(n = 26) of patients had class I in Raymond-Roy occlusion classification, 22% (n = 9) had class II, and 14.6% (n = 6) 
had class III. Complications of the procedure were observed in 17.5% (n = 7) of patients: 22.2% (n = 4) with ruptured 
and 13.6% (n = 3) with unruptured aneurysms.
Conclusions: Endovascular treatment of MCA aneurysms is feasible, and our results are convergent with other stud-
ies. Ruptured MCA aneurysms may be treated endovascularly with similar effects as unruptured MCA aneurysms.  
The complication rate of such treatment is low.
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Introduction
The middle cerebral artery (MCA) is one of the most fre-
quent locations of intracranial aneurysms (IA). Their share 
of IA ranges from 20 to 43% [1,2]. The basic approach to 
MCA aneurysm treatment is neurosurgical clipping, which 
is well established [3-6]. Moreover, ruptured MCA aneu-
rysms usually require surgical treatment of the adjacent 
haematoma [7]. At the same time, endovascular therapy for 
MCA aneurysms is available, with the first study compar-
ing MCA aneurysm clipping and endovascular treatment 
published in 1999 [4]. The endovascular treatment of in-
tracranial aneurysms is developing rapidly. The role of the 
endovascular approach in MCA aneurysm treatment is 
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constantly increasing, with new devices allowing for treat-
ment of more complex aneurysms [7-10]. 
MCA aneurysms are considered challenging for endo-
vascular treatment due to the anatomy of MCA and their 
localisation. The diameter of MCA is relatively small, and 
aneurysms often incorporate branches arising from MCA 
trunk. The choice of treatment method should be based 
on size, location, and neck size of the aneurysm, as well 
as comorbidities and patients’ age. The choice between 
clipping and endovascular procedure, as well as between 
different types of endovascular procedures, is crucial for 
the success of treatment.
Intracranial aneurysms are the most common cause of 
subarachnoid haemorrhage (SAH). It often occurs in young 
patients and is the cause of loss of productive life years in 
the same rate as seen in cerebral stroke [11]. It is estimated 
that about 50% of patients with an SAH episode die and 
20% suffer from its complications [12]. 
Advances in technology have led to an increase in 
the number of aneurysms treated by endovascular pro-
cedures. Nonetheless, more data are needed to support 
their quality and safety. The aim of this study was to sum-
marise the eight years of experience of our department in 
endovascular treatment of MCA aneurysms, and to com-
pare the results of treatment of ruptured and unruptured 
aneurysms.
Material and methods
After obtaining approval from the institutional Bioethics 
Committee, we retrospectively assessed all procedures of 
endovascular treatment of intracranial aneurysms from 
2013 to 2018. All patients aged 18 years and older, who 
had undergone embolisation of MCA aneurysm, were 
included.
Forty patients with 41 MCA aneurysms were treated. 
Eighteen (45%) men with 19 (46.3%) aneurysms were 
included in this group. Mean age of patients was 56.15 
(± 13.86; range 25-92) years. In our group, 43.9% (n = 18) 
of patients had SAH due to MCA aneurysm rupture, while 
56.1% (n = 23) were treated for unruptured aneurysms.
The procedures were performed under general anaes-
thesia with the use of a mono-plane Axiom Artis dFA 
angiography system equipped with 3D DSA and Dyna 
CT connected with workstation reconstruction software 
(Siemens Healthcare, Erlangen, Germany). 
In all patients who underwent the procedure, data 
on age and sex, neurological status (assessed with the 
Glasgow Coma Scale, Hunt-Hess scale, and World Fede-
ration of Neurosurgical Societies scale), and incidence 
of subarachnoid haemorrhage were collected. The inci-
dence of comorbidities, such as: hypertension, diabetes, 
ischaemic heart disease, hypercholesterolaemia, obesity, 
lung, kidney, and liver diseases, and history of myocardial 
infarction, ischaemic stroke, and subarachnoid haemor-
rhage was also evaluated.
Next, aneurysm morphology was assessed based on 
three-dimensional digital subtraction angiography (3D 
DSA) studies. Two independent researchers measured the 
dimensions. Aneurysm shape, maximal height, maximal 
width, neck width, and inflow angle were determined. 
Aneurysm shape was defined as spherical if its height, 
width, and diameter perpendicular to its width were equal; 
ellipsoid if only the width and height were equal, and irreg-
ular if it could not be categorised into the previous groups. 
Then, morphological indexes, such as aspect ratio (AR), 
width-to-height ratio (WH), and bottleneck factor (BNF) 
and, using AngioCalc calculator (www.angiocalc.com), 
aneurysm volume and percentage packing volume were 
calculated. Inflow angle, defined as the angle between par-
ent vessel and maximal height of the aneurysm dome was 
measured. To evaluate the aneurysm location, they were 
classified to four groups: in MCA bifurcation, in further 
branches, by lenticulostriate arteries and by early cortical 
branches. The M1 segment length was also measured.
The treatment course was evaluated: number of endo-
vascular procedures, recanalisation rate, type of endovas-
cular procedure (coiling, balloon-assisted coiling, stent-
assisted coiling, Y-stenting, flow diverter, pCONus), as 
well as the results of embolisation in the Raymond-Roy 
scale. The recorded complications included bleeding dur-
ing procedure, relocation of coils during the procedure, 
formation of thrombus during the procedure, transfer to 
an intensive care unit, and death.
Continuous variables were analysed using Student’s 
t-test or Mann-Whitney test, and categorical variables 
were analysed using chi-square analysis. In all analyses, 
p < 0.05 was considered statistically significant. All statis-
tical analyses were performed using Statistica version 12.5 
(StatSoft Inc., Tulsa, OK, USA).
Results
Morphology of aneurysms and middle cerebral artery 
The localisation of the aneurysms is shown in Figure 1. 
Aneurysms in bifurcation of MCA were the most com-
monly treated. The morphological features of aneurysms 
Figure 1. Localization of treated middle cerebral artery aneurysms. 
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are presented in Table 1. There were no statistically signifi-
cant differences in terms of aneurysm morphology between 
males and females and between ruptured and unruptured 
aneurysms, although ruptured aneurysms tended to be 
larger. However, differences in M1 segment length were 
observed between patients with ruptured and unruptured 
aneurysms (13.3 ± 3.7 vs. 17.5 ± 6.3, p = 0.0155). M1 seg-
ment lengths ranged from 5.3 mm to 19.8 mm in patients 
with ruptured aneurysms and from 7.1 mm to 33.0 mm 
in patients with unruptured aneurysms. 42.5% (n = 17) of 
patients had multiple aneurysms. 32.4% (n = 10) had one 
additional aneurysm, 10% (n = 4) had two additional aneu-
rysms, 2.5% (n = 1) had three additional aneurysms, and 
5% (n = 2) had four additional aneurysms. 32.5% (n = 13) 
of patients had additional ipsilateral MCA aneurysms and 
7.5% (n = 3) had mirror MCA bifurcation aneurysms. 
Comorbidities
None of the diseases analysed in the current study were 
linked with significantly increased risk of SAH. Past his-
tory of SAH, ischaemic stroke, or myocardial infarction 
and family history of aneurysms were distributed equally 
in both groups. Tobacco smoking and alcohol use disorder 
did not correlate with the incidence of SAH. 
Treatment method
In ruptured aneurysms, 15 patients were treated by coiling 
alone, two by balloon-assisted coiling, and one by stent-
assisted coiling. In unruptured aneurysms, seven were 
treated by coiling alone, three by balloon-assisted coiling, 
10 by stent assisted coiling (1 Y-stenting), two by flow di-
verter, and one by pCONus with coils. Three aneurysms 
treated with stents due to wide neck and high tortuosity 
of M2 MCA branches were treated with two-stage pro-
cedure. In total, 44 endovascular procedures were per-
formed: 38 aneurysms were treated in a one-stage proce-
dure, while three required a planned two-stage procedure.
Five of the unruptured aneurysms were retreated due 
to recanalisation after surgical clipping (Figure 2A-D). 
Unruptured aneurysms were significantly more fre-
quently treated by stent-assisted coiling (30.4% vs. 5.6%, 
p = 0.0388) than ruptured aneurysms, while ruptured 
aneurysms were treated more frequently by coiling alone 
(77.8% vs. 34.8%, p = 0.0062). No connection of morpho-
logical features and treatment method was found.
Immediate treatment results
After the initial course of treatment 63.4% (n = 26) of pa-
tients had class I aneurysms in Raymond-Roy occlusion 
classification, 22% (n = 9) had class II, and 14.6% (n = 6) 
had class III. Mean packing density was 26.20 ± 0.20%. No 
significant difference in packing density (30.6% vs. 20.8%; 
p = 0.2939) and class in Raymond-Roy occlusion classifi-
Table 1. Morphology of ruptured and unruptured aneurysms. All p >0.05





Spherical 51.2 44.4 56.5
Ellipsoid 24.4 27.8 21.7
Irregular 24.4 27.8 21.7
Diameters (mm)
Neck width 3.44 3.48 3.42
Maximal height 4.03 4.50 3.90
Maximal width 4.71 4.81 4.60
Width 2 3.95 4.66 3.80
AR 1.15 1.24 1.13
WH 1.14 1.23 1.31
BNF 1.44 (± 0.52) 1.57 (± 0.67) 1.33 (± 0.35)
Other
Inflow angle (o) 121.73 (± 32.29) 125.52 (± 31.85)118.76 (± 33.04)
Volume (mm3) 31.77 69.42 20.25
cation (1.7 ± 0.8 vs. 1.4 ± 0.6; p = 0.2085) was detected be-
tween ruptured and unruptured aneurysms. No connection 
between treatment method and better outcomes was found.
Complications
Complications of the procedure were observed in 17.5% 
(n = 7 out of 40) of patients: 22.2% (n = 4 out of 18) with 
ruptured and 13.6% (n = 3 out of 22) with unruptured 
aneurysms (p = 0.48). 
Bleeding from the aneurysm during procedure oc-
curred in 5% (n = 2) of patients. In one patient with SAH 
the bleeding, which appeared after aneurysm perforation 
during coil packing, was stopped by balloon inflation. In 
one patient unruptured aneurysm bleeding, which was 
a result of microwire perforation of aneurysm sac, was 
stopped by coil implantation. Relocation of coils into the 
lumen of the vessel occurred in 5% (n = 2) of patients 
without flow disturbances and thromboembolic events.
Thromboembolic complications occurred in 5% (n = 2) 
of patients, both treated with balloon-assisted coiling. In one 
patient with ruptured aneurysm, mechanical thrombectomy 
of M1 occlusion was performed, but complete recanalisa-
tion was not achieved, and the patient died due to ischaemic 
changes. In the patient with unruptured aneurysm, asymp-
tomatic ischaemic stroke in an area supplied by the branch 
originating from the aneurysm neck was detected in post-
procedural CT three days after the procedure, with no neu-
rological deficits. 
In 2.5% (n = 1) of patients, dissection of the internal 
carotid artery with no haemodynamic disturbances oc-
curred, but it was complicated by persistent mild aphasia. 
 MCA aneurysm endovascular treatment 
e653© Pol J Radiol 2020; 85: e650-e656
Figure 2. A) Recurrent left middle cerebral artery bifurcation aneurysm 
after surgical clipping. B-C) Y-stenting coil embolization. Follow-up con-
trast magnetic resonance angiography (MRA) shows total occlusion of 




Seven patients with SAH required hospitalisation in 
intensive care unit, and three of them died. Among pa-
tients with unruptured aneurysms none died. Aneurysm 
morphology, aneurysm rupture, method of endovascular 
treatment, packing density, and neurological state have 
been found not to be connected with increased risk of 
intra-procedural complications.
Follow-up
In 54% of patients (n = 20) diagnostic imaging follow-up 
(DSA, MRI and CT angiography studies) was available. 
The mean time of follow-up on diagnostic imaging was 1.6 
± 1.7 years. Recanalisation occurred in four patients (three 
with SAH and one without SAH). One unruptured and 
two ruptured aneurysms were retreated once due to reca-
nalisation and one ruptured aneurysm had two treatments 
of recanalisation. Recanalisation of aneurysms was treated 
by coiling alone in one case, by stenting alone in one case, 
by stent-assisted coiling in two cases, and by pCONus with 
coils in one case. All treatments of recanalisation achieved 
class I in Raymond-Roy occlusion classification.
Clinical follow-up 30 days after the procedure was avail-
able for eight patients, with six patients scoring 0 points 
on modified Rankin Scale (mRS), and two patients with 
2 points on mRS. Delayed clinical follow-up was avail-
able for 16 patients, with a mean time of follow-up of 2.9 
± 2.4 years. Thirteen patients scored 0 points on mRS, two 
patients scored 1 point, and one patient scored 4 points, for 
the mean of 0.6 ± 1.2 points.
The overall probability of any incident-free survival 
was 90.3%; in the group with SAH it was 80% and in the 
group without SAH 95.2%. The total probability of severe 
complications (intraprocedural bleeding and thromboem-
bolic complications) was 20% (Figure 3).
Discussion
MCA aneurysms were considered challenging to treat by 
endovascular approach, probably due to the anatomy of 
MCA. Nearly 90% of MCA aneurysms are located in the 
M1 segment division; from 3.57% to 13.33% in distal M2 
segment divisions [13]. Thus, aneurysms localised in the 
MCA trunk division may incorporate the enbranchnig 
vessel, which makes the procedure difficult [5]. Develop-
ments in imaging techniques allowed for better assessment 
of MCA anatomy and more appropriate use of adjunc-
tive devices. The introduction of compliant balloons and 
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self-expanding stents to clinical practice has changed the 
approach to wide-necked aneurysms. New devices that 
aim to increase the share of MCA aneurysms treated en-
dovascularly are constantly being developed. Devices like 
pCONus (Phenox, Bochum, Germany) and PulseRider 
(Pulsar Vascular, Los Gatos, CA, USA) are used as an alter-
native to double-stenting methods to treat wide-necked an-
eurysms located in arterial bifurcations [14,15]. Two cases 
treated with pCONus are presented in this series. Another 
one is the Woven EndoBridge, an intraluminal device that 
is used as an alternative to coils [16].
Previously endovascular approach was also more likely 
to cause thromboembolic complications. Development of 
new anticoagulation treatments has largely contributed to 
limiting of those events [17]. A randomised trial points 
out that coiling may be more beneficial for patients with 
SAH in different localisations compared to microsurgical 
treatment [18]. However, it may differ in MCA aneurysms. 
Recent studies have shown that endovascular treatment 
may be a proper approach in MCA aneurysm treatment 
after considering neurosurgery [7]. The results of this study 
are similar to those previously published.
The aneurysm morphology measurements showed no 
differences between ruptured and unruptured aneurysms. 
Ruptured aneurysms had a tendency to be larger (median 
volumes 20.25 vs. 69.42 mm3; p = 0.21), but this param-
eter differs between studies [19,20]. It may be due to the 
fact that most of the studies include rather limited series 
of MCA aneurysms. Kadkhodayan et al. demonstrated 
in their study with the largest series of 346 aneurysms 
that the mean size of ruptured aneurysm was signifi-
cantly greater [21]. The median aneurysm neck width was 
3.44 mm, which is similar to the results other studies 
[17,22]. Table 2 presents a comparison of recent studies 
concerning MCA aneurysms treatment. Our study also 
shows that M1 length can contribute to MCA aneurysm 
rupture. Haemodynamic factors are a known contributor 
to both aneurysm formation and rupture. No previous clin-
ical study has found any correlation of M1 length and rup-
ture of the aneurysm; however, M1 length has been prov-
en to be associated with MCA aneurysm formation [23]. 
Further studies on a larger group of patients are needed to 
determine its clinical significance.
In 65% of patients complete occlusion of the aneurysm 
was achieved. Ruptured aneurysms were more difficult to 
occlude, but without statistical significance. These results 
were convergent with previous studies. 
Thromboembolic events are considered to be the most 
common complication during aneurysm coiling [27]. In 
our study thrombus formation occurred in 5% of cases. 
Figure 3. Kaplan-Meier event-free survival courses for patients undergoing 
middle cerebral artery aneurysms endovascular treatment. Overall survival 
free any events (A) in patients with and without subarachnoid haemor-
rhage (B). Cumulative survival freedom for patients with complications 
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In other recent studies, thromboembolism seems to be 
a much more common complication. A comparison of 
complications is also presented in Table 2.
Limitations of this study include its retrospective na-
ture, limited group of patients, and long duration of ob-
servation, during which the devices used to perform the 
procedures were constantly changing. 
Conclusions
Endovascular treatment of MCA aneurysms is feasible. Rup-
tured MCA aneurysms may be treated endovascularly with 
similar effects as unruptured MCA aneurysms. The compli-
cation rate of such treatment is low. 
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Table 2. Comparison of recent studies of endovascular treatment of middle cerebral artery aneurysms. RR1 – Raymond-Roy class I, RR2 – Raymond-Roy 
class II, RR3 – Raymond-Roy class III
Parameters This study Link et al. [17] Kadkhodayan et al. [24] Kim et al. [25] Abla et al. [26]
Demographic statistics
Mean age (years) 56.15 (± 13.86) 57 (± 15) – 56.70 60.27 (± 10.77)
Males, n (%) 18 (45) 26 (27.96) 95 (27.46) 13 (43.33) 10 (29.61)
Female, n (%) 22 (55) 67 (67.04) 251 (72.54) 17 (56.67) 23 (69.70)
Number of aneurysms 41 94 (93 cured) 346 (341 cured) 30 34
Aneurysm statistics
Ruptured, n (%) 18 (43.90) 40 (43.01) 95 (27.46) 3 (10) 15 (44.12)
Unruptured, n (%) 23 (56.10) 53 (56.98) 251 (72.54) 27 (90) 19 (55.88)
Retreatments, n (%) 4 (9.76) 6 (6.45) 19 (5.49) – 7 (20.59)
Diameters (mm)
Maximal diameter 4.71 (± 2.63) 6.01 (± 2.73) 6.6 – 10.55 (± 7.50)
Maximal neck width 3.44 (± 1.64) 3.25 (± 1.20) 3.0 – 3.39 (± 1.41)
Aspect ratio 1.15 (± 0.77) 1.87 (± 0.61) – – 3.18 (± 2.10)
Treatment method, n (%)
Coil embolisation 22 (50.00) 50 (53.76) 86 (24.86) 17 (56.80) 21 (61.76)
Stent – assisted (stenting  
+ stenting and coiling)
14 (31.82) 19 (20.43) 26 (7.51) 3 (10.00) 11 (33.33)
Balloon assisted 5 (11.36) 24 (25.81) 230 (66.47) 2 (6.70) 1 (3.00)
Other 2 – flow diverter (4.55)
1 – pCONus (2.27%)
– 4 flow diversion  
pipeline (1.16)
8 double  
microcatheter (26.70)
2 ICA stenting (6.10)
Procedure outcomes, n (%)
RR1 26 (63.40) 56 (60.21) 324 (96.14) *complete  
or nearly complete
28 (93.33) *complete 10 (29.40)
RR2 9 (22.00) 25 (26.88) 15 (44.10)
RR3 6 (14.60) 9 (9.67) 13 (3.86) 2 (6.67) *residual aneurysm 7 (20.60)
Complications (intraprocedural), n (%)
TE and strokes 2 (5.0) 18 (19.35) 47 (13.60) 2 (6.67) 4 (12.12)
Haemorrhages  
and aneurysm ruptures
2 (5.0) 2 (2.15) 9 (2.60) 0 7 (21.21)
Coil relocation 2 (5.0) 2 (2.15) – 1 (3.33) –
Artery dissection 1 (2.5) 1 (1.08) – 0 2 (6.06)
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